why choose us

First received: August 19, 2022

Clinical Trial: Expanded Access [11C] Methionine PET Imaging

Condition: Central Nervous System Tumor
Head and Neck Neoplasms

Study Type: Expanded Access


Official Title: Expanded Access [11C] Methionine PET Imaging

Brief Summary: The participants are being asked to get this PET scan because the participants have or may have cancer in the central nervous system (head, neck, or spine), and the investigator and the patient's physician thinks that this scan may provide useful information for the participant's treatment.Primary ObjectiveTo provide expanded access to L-[11C]methionine as a positron-emitting tracer in children and young adults for the positron emission tomography (PET) imaging of neoplasms of the central nervous system (CNS) and…

Read more